O webinar “Raising the bar for patients with HR+/HER2- early breast cancer” decorre já para a semana, em 25 de maio, em formato virtual. “Clinicopathologic and molecular tools for assessing risk when managing patients with HR+/HER2- early breast cancer”, “Updates and clinical implications of the latest evidence on CDK4/6 inhibitors, “MDT presentation…
Por favor faça login ou registe-se para aceder a este conteúdo